Opiant Pharmaceuticals has announced that their nasal spray, Narcan, which reverses opioid overdoses, will be sold for “less than $50” per kit. The announcement comes after the US government gave the company a $4.6 million contract to develop the spray. Although praised as a positive step in the fight against the opioid epidemic, critics say the price should be even lower, with a congressman urging the company to lower the price further. The Narcan spray is an important tool in the emergency treatment of opioid overdoses, blocking the effects of the drug and saving lives.
Today: December 9, 2023